BMY-14802, a sigma ligand and potential antipsychotic drug, reverses amphetamine-induced changes in neostriatal single-unit activity in freely moving rats
- 1 December 1992
- Vol. 12 (4) , 312-321
- https://doi.org/10.1002/syn.890120408
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Clozapine: An atypical neurolepticNeuroscience & Biobehavioral Reviews, 1991
- Movement Disorder Associated with Antipsychotic Drugs: The Tardive SyndromesInternational Review of Psychiatry, 1990
- A simple device for the reliable production of varnish-insulated, high-impedance tungsten microelectrodesJournal of Neuroscience Methods, 1989
- Heterogenous responses of neostriatal neurons to amphetamine in freely moving ratsBrain Research, 1988
- The Sigma ReceptorClinical Neuropharmacology, 1988
- The PAW test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphismLife Sciences, 1988
- Interactions between dopamine and amino acid-induced excitation and inhibition in the striatumBrain Research, 1986
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- Tardive dyskinesiaNeurology, 1984
- Results and side effects of treatment with clozapine (leponex R)Comprehensive Psychiatry, 1977